Skip to main content

Greedy Insider

HRMY Insider Trades and Greediness Scores

Harmony Biosciences Holdings, Inc. (HRMY) insider trades: since Dec 5, 2025, Greedy Insider recorded 0 open-market buys and 22 sales on Form 4 from 5 insiders. The strongest recent filing scored 83 (Strong).

Who bought and who sold

Across the last 22 scoreable Form 4 transactions in HRMY, 0 were open-market purchases and 22 were sales. The table lists the most recent filings with each one's Greediness Score, so the structurally unusual trades are easy to spot first.

InsiderRoleTypeSharesDateScore
Budur KumarCHIEF MEDICAL OFFICERSell35852.01543589.92026-09-1883View
Budur KumarCHIEF MEDICAL OFFICERSell800.034400.02026-09-1762View
Budur KumarCHIEF MEDICAL OFFICERSell1800.077426.282026-09-1662View
Budur KumarCHIEF MEDICAL OFFICERSell22954.0989349.562026-09-0880View
Budur KumarCHIEF MEDICAL OFFICERSell4500.0190113.752026-09-0868View
Budur KumarCHIEF MEDICAL OFFICERSell1000.042794.72026-09-0862View
Budur KumarCHIEF MEDICAL OFFICERSell5500.0230911.452026-09-0467View
Budur KumarCHIEF MEDICAL OFFICERSell8882.0282714.062026-05-0163View
Zaeske Adam H.CHIEF COMMERCIAL OFFICERSell3173.087638.262026-04-0772View
Kapadia SandipCFOSell3746.0139171.392026-01-2672View

The strongest recent filing

Budur Kumar (CHIEF MEDICAL OFFICER) sold 35,852 shares of Harmony Biosciences Holdings, Inc. on Sep 18, 2026, a filing that scored 83 (Strong). It scored Strong because a senior insider was trading and it was direct personal ownership. The score describes the filing, not future returns. This is not investment advice.

Cluster activity

No cluster buy is present in the current window: the recent HRMY filings do not show three or more insiders buying together inside seven days.

How this compares with Harmony Biosciences Holdings, Inc.'s own history

Open-market buys make up 0% of the 22 scoreable HRMY transactions on record between Dec 5, 2025 and Sep 18, 2026. Comparing a filing with the company's own buy/sell mix is how you tell a routine disposal from an unusual accumulation.

Methodology and sources

Scores come from six published, user-adjustable factors (insider role, cluster activity, trade size versus the insider's own history, position impact, filing urgency, and direct versus indirect ownership). The score describes the filing, not future returns. This is not investment advice.

Key facts

  • Scoreable Form 4 transactions on record: 22
  • Open-market buys: 0
  • Sales: 22
  • Distinct insiders: 5
  • Strongest recent Greediness Score: 83 (Strong)

Primary sources

Related

The score describes the filing, not future returns. This is not investment advice.